"At Aperture, we bring the universe down to Earth and explore the human condition through thought-provoking stories, mind-bending concepts, and groundbreaking discoveries. Follow us for more ...

FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024Entered into asset purchase agreement ...

FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million Company to host confer ...

Some cars had the looks, handling, and appeal but were let down by bad engines. Whether unreliable or underpowered, they fell ...

Neurenati Therapeutics Inc., a biotech company focused on rare pediatric diseases, is pleased to announce that the U.S. Food ...

“With the backing of Carlyle and SK Capital, we will bring the capital and commercial capabilities needed to accelerate and expand patient access to bluebird’s life-changing gene therapies.

I know it's part of getting older, but when my husband was told to go to the ER because a clinical trial EKG had revealed an irregular heartbeat, I was startled almost into one of my own.

Jazz Pharma to buy biopharmaceutical company, Chimerix for approximately $935 million: Dublin Friday, March 7, 2025, 14:00 Hrs [IST] Jazz Pharmaceuticals plc, a global biopharmace ...

Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors- -Transaction to add near-term commercial opportunity to Jazz's pipeline- -Transaction ...

From 2019-2023, North Carolina increased the number of life sciences business establishments by 43%. To learn more in the TEConomy 2024 report, click here.